查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
透皮给药系统市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用和配销通路
市场调查报告书
商品编码
1389614

透皮给药系统市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用和配销通路

Transdermal Drug Delivery System Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 233 Pages | 订单完成后即时交付

价格

全球透皮给药系统市场预计将从2022年的372.3亿美元增至2030年的519.49亿美元。预计2022年至2030年该市场将以4.3%的CAGR成长。

推动市场成长的关键因素包括透皮给药系统应用领域的不断扩大和脊髓损伤病例的增加。然而，术后併发症阻碍了市场的成长。

透皮给药系统市场的市场机会

经皮给药途径是新颖的，也是持续给药的可靠方法之一。随着这一领域的大量研究的开展以及研究人员对这种药物输送形式的兴趣日益浓厚，未来可能会有大量透皮贴片进入市场。透皮贴片用于输送尼古丁、芬太尼、硝酸甘油和可乐定等药物来治疗各种疾病。最近，这些贴片已被探索在各种应用中提供生物製剂。智慧贴片配备了感测器和其他技术来监测患者状况并相应调整药物传递。 2023 年 1 月，斯旺西大学的一位首席科学家开发了一种新型智慧贴片，利用微针技术检测帕金森氏症和阿兹海默症等神经退化性疾病的促炎生物标记。这些智慧贴片包含大量微针，旨在以微创方式穿透皮肤屏障，然后监测具有临床意义的生物标记。它们可以在全科诊所或家中自我管理以进行即时诊断。这项创新研究可能会改变早期神经退化性疾病检测的格局。

根据2021年11月发表在美国国家医学图书馆的一篇题为《局部皮肤应用的3D列印产品：从个人化敷料到药物输送》的文章称，贴合皮肤表面的个人化3D列印贴片可用于乙酰化-六肽3 (AHP-3) 递送。在这项研究中，两种液体单体——聚乙二醇二丙烯酸酯（PEGDA）和乙烯基吡咯烷酮（VP）——以不同的比例使用，以提高最终聚合物的机械强度、聚合速率和溶胀速率。树脂上的最佳载药量表明 AHP-3 在整个製造过程中保持稳定，并且对最终聚合物的物理性能没有影响。使用 3D 扫描脸部模型，在电脑辅助设计软体中设计个人化贴片，并使用数位光处理 3D 列印机在优化树脂中製造。製备的透皮贴片的体外表征表明它们能够穿透人体尸体皮肤，并在压缩后进一步保持完整。 「用于局部皮肤应用的3D 列印产品：从个人化敷料到药物输送」是第一个展示使用光聚合物製成的个人化贴片的研究，它引入了一种改善药物透皮输送的新方法，以实现有效的皱纹管理。

因此，3D列印技术和智慧贴片的采用可能会在未来几年为透皮给药系统市场提供机会。

阻碍经皮给药系统市场的因素

目前市售的透皮给药系统（TDDS）、透黏膜给药系统（TMDS）和局部贴片在预期使用期后可能会保留初始药物总量的10-95%作为残留药物。这给患者及其家人和照护者带来了潜在的安全问题。例如，由于患者在预期使用期结束时未能去除TDDS而导致的不良事件通常会导致药物的药理作用增加或延长。据报道，一些儿童因意外接触废弃的 TDDS 而死亡。以下是製造商召回和撤回的一些产品。

2023 年 2 月，Aveva Drug Delivery Systems Inc 因不符合杂质/降解规格而召回了两批丁丙诺啡透皮系统。 Aveva 药物输送系统于 2023 年 2 月 15 日主动启动召回，并于 2023 年 3 月 14 日被 FDA 指定为 III 级召回。在此召回分类下，该产品的使用不太可能造成任何重大危害。 2020年9月，美国梯瓦製药公司召回了两批丁丙诺啡贴片。此次召回涉及批次190017 和190161 的32,543 箱丁丙诺啡透皮系统，5 微克/小时，每箱四个透皮系统（补丁NDC 0093-3656-21，纸箱NDC 0093-3656-40）。该产品由3M 製造梯瓦製药 (Teva Pharmaceuticals) 的给药系统，在美国和波多黎各分销。继 Teva Pharmaceuticals 于 2020 年 9 月 4 日自愿召回后，FDA 于 2020 年 10 月 1 日将召回指定为 II 级。继续使用 II 级召回产品可能会导致暂时或医学上可逆的不良健康后果。虽然距离遥远，但存在造成严重伤害的可能性。此外，2018 年 4 月，FDA 向 Phase 4 Pharmaceutical LLC 发出警告信。该公司不是生产透皮药物类型，而是作为非处方 (OTC) 透皮药物类型的重新包装商，FDA 发现了几项违反 CGMP 的行为，影响了其产品品质。 2019 年 4 月，Alvogen, Inc. 宣布在全国范围内自愿召回两批（或批次）芬太尼透皮系统（12 微克/小时透皮贴剂），原因是标籤混淆。因此，透皮给药系统的不良反应和召回阻碍了市场的成长。

透皮给药系统市场：细分概述

根据产品，透皮给药系统市场分为透皮贴片、透皮凝胶、透皮喷雾等。透皮贴片细分为药物贴片贴片、储库膜贴片、基质贴片及蒸气贴片。透皮贴片细分市场在 2022 年占据最大市场份额，而透皮凝胶预计在 2022 年至 2030 年期间复合CAGR最高。透皮贴片是附着在患者皮肤上以透过皮肤输送药物的药物传递系统。

透皮给药系统市场按应用细分为心血管疾病、中枢神经系统疾病、荷尔蒙应用、疼痛管理和其他应用。疼痛管理市场细分为鸦片类药物应用和非鸦片类药物应用。荷尔蒙应用领域的市场进一步细分为透皮雌激素疗法和睪固酮替代疗法。疼痛管理细分市场在 2022 年占据最大市场份额。中枢神经系统疾病细分市场预计在 2022 年至 2030 年期间将实现最高的CAGR。

根据配销通路，透皮给药系统市场分为医院药房、零售药房、网路药房等。医院药局细分市场在 2022 年占据最大市场份额。然而，零售药局细分市场预计在 2022 年至 2030 年期间将实现最高的CAGR。

透皮给药系统市场：地理概况

2022年，北美在全球透皮给药系统市场中占据最大份额。在该地区，美国拥有最大的透皮给药系统市场份额，预计2022-2030年CAGR最高。根据美国心臟协会 (AHA) 的数据，心血管疾病 (CVD) 仍然是美国的首要死因。据 CDC 称，2021 年，CVD 导緻美国约 695,000 人死亡，约占美国五分之一的死亡人数。心血管疾病、糖尿病、慢性疼痛和其他慢性疾病的盛行率不断上升，推动了对有效、便利的治疗方案的需求。医疗贴片提供了一种非侵入性且患者友善的方法来提供药物并管理与这些慢性病相关的症状。 TDDS 的不断进步，例如穿戴式感测器和柔性电子产品，有助于透皮给药系统市场的成长。这些进步可以实现更准确的剂量、增强的患者监测并提高患者的依从性。根据Biomaterials Research 2021 年发表的题为《透皮给药系统的最新进展》的报告，微针在TDDS 模式中引起了极大关注，它结合了微针的优点，克服了现有简单涂抹型和贴片型针的限制。微针以获得更高的治疗效率和效果。这些TDDS的进展可以为控制心血管和中枢神经系统疾病、糖尿病、神经肌肉疾病以及传染病和局部传染病的流行提供动力。

个性化药物的不断增长趋势，即针对个别患者量身定制治疗方案，促进了提供受控和有针对性的药物输送的医疗贴剂的开发。这种客製化可以改善患者的治疗效果并提高治疗效果。例如，2020年，Reddy's Laboratories在美国市场推出了NitroDur（硝化甘油）透皮输注系统的授权仿製药。随着人们对家庭医疗保健和远端患者监测的日益重视，医疗贴片为在传统医疗保健环境之外输送药物和监测生命体征提供了便捷的解决方案。美国透皮给药系统市场受到慢性病盛行率上升、技术进步以及对个人化药物日益关注等因素的影响。

在准备透皮给药系统市场报告时提到的一些主要一手和二手来源包括世界银行数据、国家卫生服务体系 (NHS)、FDA（食品和药物管理局）、EMA（欧洲药品管理局）、和WHO（世界卫生组织）。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解
  • 透皮给药系统市场（按地域）

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：透皮给药系统市场格局

  • 概述
  • 全球PEST分析

第 5 章：透皮给药系统市场 - 主要产业动态

  • 市场驱动因素
    • 慢性病盛行率增加
    • 对非侵入性给药设备的需求不断增长
    • 自我用药需求旺盛
  • 市场限制
    • 经皮给药系统的不良反应与召回
  • 市场机会
    • 智慧补丁和 3D 列印补丁的进步
  • 未来的趋势
    • 製造商的策略倡议
  • 影响分析

第 6 章：透皮给药系统市场 - 全球市场分析

  • 经皮给药系统市场收入，2022 - 2030

第 7 章：透皮给药系统市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年按产品分類的透皮给药系统市场收入份额 (%)
  • 透皮贴剂
  • 透皮凝胶
  • 透皮喷剂
  • 其他的

第 8 章：全球透皮给药系统市场 - 收入和 2030 年预测 -按应用

  • 概述
  • 2022 年和 2030 年按应用分列的透皮给药系统市场收入份额 (%)
  • 心血管疾病
  • 中枢神经系统疾病
  • 疼痛管理
  • 荷尔蒙应用
  • 其他应用

第 9 章：全球透皮给药系统市场 - 收入和 2030 年预测 - 按配销通路

  • 概述
  • 2022 年和 2030 年按配销通路的透皮给药系统市场收入份额 (%)
  • 医院药房
  • 零售药局
  • 网路药局
  • 其他的

第 10 章：透皮给药系统市场 - 2030 年收入与预测 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：透皮给药系统市场产业格局

  • 概述
  • 透皮给药系统市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Novartis AG
  • Johnson & Johnson
  • GSK Plc
  • Viatris Inc
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co Inc
  • Luye Pharma Group Ltd
  • Lavipharm SA
  • Purdue Pharma LP
  • UCB SA

第 13 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00002894

The global transdermal drug delivery systems market is expected to reach US$ 51.949 billion in 2030 from US$ 37.230 billion in 2022. The market is estimated to grow with a CAGR of 4.3% from 2022 to 2030.

The key factors driving the market's growth include growing areas of application of transdermal drug delivery systems and rising cases of spinal cord injury. However, the post-surgical complications hinder the market growth.

Market Opportunities of Transdermal Drug Delivery Systems Market

A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.

According to an article titled "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery," published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery" is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.

Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.

Factors Hampering Transdermal Drug Delivery Systems Market

Currently marketed transdermal drug delivery systems (TDDS), transmucosal drug delivery systems (TMDS), and topical patches may retain 10-95% of the initial total quantity of the drug as a residual drug after the intended use period. This raises a potential safety issue for patients, and their family members and caregivers. For example, adverse events due to a patient's failure to remove TDDS at the end of the intended use period generally result in an increased or prolonged pharmacological effect of the drug. Some children have also been reported to have died from accidental exposure to discarded TDDS. Below are some of the product recalls and withdrawals by the manufacturers.

In February 2023, Aveva Drug Delivery Systems Inc recalled two lots of buprenorphine transdermal systems for failing to meet impurity/degradation specifications. Aveva Drug Delivery Systems voluntarily initiated the recall on February 15, 2023, which was designated as a Class III recall by the FDA on March 14, 2023. Under this recall classification, the use of the product is not likely to cause any major harm. In September 2020, Teva Pharmaceuticals USA recalled two lots of buprenorphine patches. The recall affected 32,543 cartons of buprenorphine transdermal systems, 5 mcg/hour, four transdermal systems per carton (patch NDC 0093-3656-21, carton NDC 0093-3656-40), from lots 190017 and 190161. The product was manufactured by 3M Drug Delivery Systems for Teva Pharmaceuticals and distributed in the US and Puerto Rico. Followed by its voluntary recall by Teva Pharmaceuticals on September 4, 2020, the FDA designated the recall Class II on October 1, 2020. Continuing the use of Class II recall products may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm exists. Further, in April 2018, the FDA sent a Warning Letter to Phase 4 Pharmaceutical LLC. Instead of manufacturing transdermal drug types, the firm was functioning as a re-packager of over-the-counter (OTC) transdermal drug types, and the FDA found several violations of CGMP that affected the quality of its products. In April 2019, Alvogen, Inc. announced a voluntary, nationwide recall of two lots (or batches) of Fentanyl Transdermal System, 12 mcg/h transdermal patches, because of a label mix-up. Thus, adverse effects and recalls of transdermal drug delivery systems hinder the market growth.

Transdermal Drug Delivery Systems Market: Segmental Overview

Based on product, the transdermal drug delivery system market is segmented into transdermal patches, transdermal gels, transdermal sprays, and others. The transdermal patch segment is further segmented into drug-in-adhesive patches, reservoir membrane patches, matrix patches, and vapor patches. The transdermal patches segment held the largest share of the market in 2022, while transdermal gels is anticipated to register the highest CAGR during 2022-2030. A transdermal patch is a drug delivery system attached to a patient's skin to deliver medication through the skin.

The transdermal drug delivery system market, by application, has been segmented into cardiovascular diseases, central nervous system disorders, hormonal applications, pain management, and other applications. The market for the pain management segment is sub-segmented into opioid application and non-opioid application. The market for hormonal application segment is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2022. Central nervous system disorders segment is expected to register the highest CAGR in the market during 2022-2030.

Based on the distribution channel, the transdermal drug delivery system market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2022. However, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022-2030.

Transdermal Drug Delivery Systems Market: Geographical Overview

North America accounted for the largest share of the global transdermal drug delivery systems market in 2022. In the region, the US held the largest transdermal drug delivery systems market share and is anticipated to register the highest CAGR during 2022-2030. According to the American Heart Association (AHA), cardiovascular disease (CVD) remains the leading cause of death in the US. According to the CDC, in 2021, CVD accounted for ~695,000 deaths and ~1 in 5 deaths in the US. The rising prevalence of cardiovascular disease, diabetes, chronic pain conditions, and other chronic diseases drives the demand for effective and convenient treatment options. Medical patches offer a noninvasive and patient-friendly approach to deliver medication and manage symptoms associated with these chronic conditions. Ongoing advancements in TDDS, such as wearable sensors and flexible electronics, contribute to the growth of the transdermal drug delivery system market. These advancements allow for more accurate dosing, enhanced patient monitoring, and improved patient compliance. According to a report titled "Recent advances in transdermal drug delivery systems," published by Biomaterials Research in 2021, microneedles attract significant attention among TDDS modalities, which overcome the limitations of the existing simple application type and patch-type needles by combining the advantages of microneedles to obtain higher treatment efficiency and effects. Advances in these TDDS can provide the driving force for controlling the prevalence of cardiovascular and central nervous system diseases, diabetes, neuromuscular diseases, and infectious and localized infectious diseases.

The growing trend of personalized medicines, where treatments are tailored to individual patients, has boosted the development of medical patches that offer controlled and targeted drug delivery. This customization allows for better patient outcomes and improved therapeutic efficacy. For instance, in 2020, Reddy's Laboratories launched an authorized generic version of NitroDur (nitroglycerin) transdermal infusion system in the US market. With the growing emphasis on home healthcare and remote patient monitoring, medical patches offer a convenient solution for delivering medications and monitoring vital signs outside traditional healthcare settings. The US transdermal drug delivery system market is influenced by factors such as the increasing prevalence of chronic diseases, rising technological advancements, and growing focus on personalized medicines.

A few of the major primary and secondary sources referred to while preparing the report on the transdermal drug delivery systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the transdermal drug delivery systems market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global transdermal drug delivery systems market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the transdermal drug delivery systems market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Transdermal Drug Delivery System Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Transdermal Drug Delivery System Market Landscape

  • 4.1 Overview
  • 4.2 Global PEST Analysis

5. Transdermal Drug Delivery System Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Growing Demand for Noninvasive Drug Delivery Devices
    • 5.1.3 High Demand for Self-Administration of Drugs
  • 5.2 Market Restraints
    • 5.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Smart Patches and 3D-Printed Patches
  • 5.4 Future Trends
    • 5.4.1 Strategic Initiatives by Manufacturers
  • 5.5 Impact Analysis

6. Transdermal Drug Delivery System Market - Global Market Analysis

  • 6.1 Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

7. Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Transdermal Patches
    • 7.3.1 Overview
    • 7.3.2 Transdermal Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Drug-in-Adhesive Patches
        • 7.3.2.1.1 Overview
        • 7.3.2.1.2 Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.2 Matrix Patches
        • 7.3.2.2.1 Overview
        • 7.3.2.2.2 Matrix Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.3 Reservoir Membrane Patches
        • 7.3.2.3.1 Overview
        • 7.3.2.3.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.4 Vapor Patches
        • 7.3.2.4.1 Overview
        • 7.3.2.4.2 Vapor Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Transdermal Gels
    • 7.4.1 Overview
    • 7.4.2 Transdermal Gels: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Transdermal Sprays
    • 7.5.1 Overview
    • 7.5.2 Transdermal Sprays: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Cardiovascular Diseases
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Central Nervous System Disorders
    • 8.4.1 Overview
    • 8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Pain Management
    • 8.5.1 Overview
    • 8.5.2 Pain Management: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.5.2.1 Opioid
        • 8.5.2.1.1 Overview
        • 8.5.2.1.2 Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.5.2.2 Non-Opioid
        • 8.5.2.2.1 Overview
        • 8.5.2.2.2 Non-Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Hormonal Applications
    • 8.6.1 Overview
    • 8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.6.2.1 Transdermal Estrogen & Progesterone Therapy
        • 8.6.2.1.1 Overview
        • 8.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.6.2.2 Testosterone Replacement
        • 8.6.2.2.1 Overview
        • 8.6.2.2.2 Testosterone Replacement: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Other Application
    • 8.7.1 Overview
    • 8.7.2 Other Application: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Retail Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Retail Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Online Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Online Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

10. Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 10.1 North America: Transdermal Drug Delivery System Market
    • 10.1.1 Overview
    • 10.1.2 North America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.1.3 North America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.1.3.1 North America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.1.4 North America: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.1.4.1 North America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.1.4.2 North America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.1.5 North America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.1 US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.1 Overview
        • 10.1.5.1.2 US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.1.3 US: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.1.3.1 US: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.1.4 US: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.4.1 US: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.4.2 US: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.1.5 US: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.2 Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.1 Overview
        • 10.1.5.2.2 Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.2.3 Canada: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.2.3.1 Canada: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.2.4 Canada: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.4.1 Canada: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.4.2 Canada: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.2.5 Canada: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.5.3 Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.1 Overview
        • 10.1.5.3.2 Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.5.3.3 Mexico: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.1.5.3.3.1 Mexico: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.1.5.3.4 Mexico: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.4.1 Mexico: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.4.2 Mexico: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.1.5.3.5 Mexico: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.2 Europe: Transdermal Drug Delivery System Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.2.3 Europe: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.2.3.1 Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.2.4 Europe: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.2.4.1 Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.2.4.2 Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.2.5 Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 10.2.6 Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 10.2.6.1 Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.1.3 Germany: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.1.3.1 Germany: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.1.4 Germany: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.4.1 Germany: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.4.2 Germany: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.1.5 Germany: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.2 France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.2.3 France: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.2.3.1 France: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.2.4 France: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.4.1 France: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.4.2 France: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.2.5 France: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.3 UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.3.3 UK: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.3.3.1 UK: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.3.4 UK: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.4.1 UK: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.4.2 UK: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.3.5 UK: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.4 Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.4.3 Italy: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.4.3.1 Italy: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.4.4 Italy: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.4.1 Italy: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.4.2 Italy: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.4.5 Italy: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.5 Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.5.3 Spain: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.5.3.1 Spain: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.5.4 Spain: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.4.1 Spain: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.4.2 Spain: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.5.5 Spain: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.2.6.6 Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.2.6.6.3.1 Rest of Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.4.1 Rest of Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.4.2 Rest of Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific: Transdermal Drug Delivery System Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.3.3 Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.3.3.1 Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.3.4 Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.3.4.1 Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.3.4.2 Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.3.5 Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
    • 10.3.6 Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 10.3.6.1 China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.1.3 China: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.1.3.1 China: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.1.4 China: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.4.1 China: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.4.2 China: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.1.5 China: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.2 Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.2.3 Japan: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.2.3.1 Japan: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.2.4 Japan: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.4.1 Japan: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.4.2 Japan: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.2.5 Japan: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.3 India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.3.3 India: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.3.3.1 India: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.3.4 India: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.4.1 India: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.4.2 India: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.3.5 India: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.4 Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.4.3 Australia: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.4.3.1 Australia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.4.4 Australia: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.4.1 Australia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.4.2 Australia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.4.5 Australia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.5 South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.5.3 South Korea: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.5.3.1 South Korea: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.5.4 South Korea: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.4.1 South Korea: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.4.2 South Korea: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.5.5 South Korea: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.3.6.6.3.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.4.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.4.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Transdermal Drug Delivery System Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.4.3 Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.4.3.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.4.4 Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
      • 10.4.4.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.4.4.2 Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.4.5 Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.1 South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.1 Overview
        • 10.4.5.1.2 South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.3 South Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.1.3.1 South Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.1.4 South Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.4.1 South Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.4.2 South Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.1.5 South Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.2 Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.1 Overview
        • 10.4.5.2.2 Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.3 Saudi Arabia: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.2.3.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.2.4 Saudi Arabia: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.4.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.4.2 Saudi Arabia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.2.5 Saudi Arabia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.3 UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.1 Overview
        • 10.4.5.3.2 UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.3 UAE: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.3.3.1 UAE: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.3.4 UAE: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.4.1 UAE: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.4.2 UAE: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.3.5 UAE: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.4.5.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.1 Overview
        • 10.4.5.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.3 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.4.5.4.3.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.4.5.4.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.4.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.4.5.4.5 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  • 10.5 South & Central America: Transdermal Drug Delivery System Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    • 10.5.3 South & Central America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
      • 10.5.3.1 South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
    • 10.5.4 South & Central America: Transdermal Drug Delivery System Market, By Application, 2020-2030 (US$ Million)
      • 10.5.4.1 South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
      • 10.5.4.2 South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    • 10.5.5 South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel, 2020-2030 (US$ Million)
    • 10.5.6 South & Central America: Transdermal Drug Delivery System Market Share by Country - 2022 & 2030, (%)
      • 10.5.6.1 Brazil: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.1.1 Overview
      • 10.5.6.2 Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
        • 10.5.6.2.1 Brazil: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.2.1.1 Brazil: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.2.2 Brazil: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.2.1 Brazil: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.2.2 Brazil: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.2.3 Brazil: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.5.6.3 Argentina: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.3.1 Overview
      • 10.5.6.4 Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
        • 10.5.6.4.1 Argentina: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.4.1.1 Argentina: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.4.2 Argentina: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.2.1 Argentina: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.2.2 Argentina: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.4.3 Argentina: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.5.6.5 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.5.1 Overview
      • 10.5.6.6 Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.6.6.1 Rest of South & Central America: Transdermal Drug Delivery System Market, by Product, 2020-2030 (US$ Million)
        • 10.5.6.6.1.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020-2030 (US$ Million)
        • 10.5.6.6.2 Rest of South & Central America: Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.2.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.2.2 Rest of South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 10.5.6.6.3 Rest of South & Central America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Transdermal Drug Delivery System Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Transdermal Drug Delivery System Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Novartis AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Johnson & Johnson
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 GSK Plc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Viatris Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Boehringer Ingelheim International GmbH
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Hisamitsu Pharmaceutical Co Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Luye Pharma Group Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lavipharm SA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Purdue Pharma LP
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 UCB SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Transdermal Drug Delivery System Market Segmentation
  • Table 2. North America Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Mexico Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Mexico Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Germany Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Germany Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. France Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. France Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. UK Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. UK Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. UK Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. UK Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. UK Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. UK Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Italy Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Italy Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Italy Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Italy Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Italy Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Italy Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Spain Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Spain Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Spain Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Spain Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Spain Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Spain Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Rest of Europe Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Rest of Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Rest of Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Rest of Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Rest of Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Rest of Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Asia Pacific Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. China Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. China Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. China Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. China Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. China Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. China Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Japan Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Japan Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Japan Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Japan Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Japan Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Japan Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. India Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. India Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. India Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. India Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. India Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. India Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Australia Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Australia Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Australia Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Australia Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Australia Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Australia Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. South Korea Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. South Korea Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. South Korea Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. South Korea Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. South Korea Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. South Korea Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Middle East & Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. South Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. South Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. South Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. Saudi Arabia Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Saudi Arabia Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Saudi Arabia Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Saudi Arabia Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Saudi Arabia Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Saudi Arabia Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. UAE Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. UAE Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. UAE Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. UAE Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. UAE Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. UAE Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 140. South & Central America: Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 141. South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 142. South & Central America: Transdermal Drug Delivery System Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 143. South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 144. South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 145. South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 146. Brazil Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 147. Brazil Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 148. Brazil Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 149. Brazil Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 150. Brazil Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 151. Brazil Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 152. Argentina Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 153. Argentina Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 154. Argentina Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 155. Argentina Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 156. Argentina Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 157. Argentina Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 158. Rest of South & Central America Transdermal Drug Delivery System Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 159. Rest of South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 160. Rest of South & Central America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 161. Rest of South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 162. Rest of South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 163. Rest of South & Central America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 164. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 165. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 166. Glossary of Terms, Transdermal Drug Delivery System Market

List Of Figures

  • Figure 1. Transdermal Drug Delivery System Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Transdermal Drug Delivery System Market: Key Industry Dynamics
  • Figure 4. Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
  • Figure 5. Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. Global Transdermal Drug Delivery System Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Transdermal Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Matrix Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Reservoir Membrane Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Vapor Patches: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Transdermal Gels: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Transdermal Sprays: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 17. Cardiovascular Diseases: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Central Nervous System Disorders: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pain Management: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Non-Opioid: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Hormonal Applications: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Testosterone Replacement: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Other Application: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 27. Hospital Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Retail Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Online Pharmacies: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Others: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. North America: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 32. North America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. North America: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 34. US: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Canada: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Mexico: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Europe: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 40. Germany: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. France: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. UK: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Italy: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. Spain: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Rest of Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Asia Pacific: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 47. Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 49. China: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. Japan: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. India: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Australia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. South Korea: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. Rest of Asia Pacific: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. Middle East & Africa: Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 56. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 57. Middle East & Africa: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 58. South Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 59. Saudi Arabia: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 60. UAE: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 61. Rest of Middle East & Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. South & Central America: Transdermal Drug Delivery System Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 63. South & Central America: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 64. South & Central America: Transdermal Drug Delivery System Market Share by Country - 2022 & 2030, (%)
  • Figure 65. Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 66. Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 67. Rest of South & Central America: Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 68. Growth Strategies in the Transdermal Drug Delivery System Market